Literature DB >> 27226409

A successful case of an anaplastic meningioma treated with chemotherapy for soft tissue sarcomas.

Maurizio Lucchesi1, Anna M Buccoliero2, Silvia Scoccianti3, Milena Guidi1, Silvia Farina1, Carla Fonte1, Claudio Favre1, Lorenzo Genitori4, Iacopo Sardi1.   

Abstract

Malignant meningioma has a bad prognosis. Surgery and radiotherapy are the most effective therapeutic options, without an established role for chemotherapy. We report a case of 2-year-old male child with diagnosis of postoperative relapse of a malignant meningioma. Considering the rapid progression, the young age and the lack of effective therapeutic alternatives, the patient underwent multidisciplinary anticancer treatment with a protocol made for soft tissue sarcomas (EpSSG NRSSTS 2005 protocol), with positive outcome. This case represents a successful management of an anaplastic meningioma with a multimodal treatment, including chemotherapy, in a pediatric patient.

Entities:  

Keywords:  anaplastic meningioma; chemotherapy; pediatric solid tumors

Mesh：

Substances：

Year:  2016        PMID： 27226409      PMCID： PMC6042637          DOI： 10.2217/cns-2016-0005

Source DB:  PubMed          Journal:  CNS Oncol        ISSN： 2045-0907


  17 in total

1.  Adjuvant combined modality therapy for malignant meningiomas.

Authors:  M C Chamberlain
Journal:  J Neurosurg       Date:  1996-05       Impact factor: 5.115

Review 2.  Diagnosis and treatment of atypical and anaplastic meningiomas: a review.

Authors:  Ashok Modha; Philip H Gutin
Journal:  Neurosurgery       Date:  2005-09       Impact factor: 4.654

3.  The treatment of recurrent unresectable and malignant meningiomas with interferon alpha-2B.

Authors:  S E Kaba; F DeMonte; J M Bruner; A P Kyritsis; K A Jaeckle; V Levin; W K Yung
Journal:  Neurosurgery       Date:  1997-02       Impact factor: 4.654

4.  Malignant meningioma: an indication for initial aggressive surgery and adjuvant radiotherapy.

Authors:  T W Dziuk; S Woo; E B Butler; J Thornby; R Grossman; W S Dennis; H Lu; L S Carpenter; J K Chiu
Journal:  J Neurooncol       Date:  1998-04       Impact factor: 4.130

5.  Recurrent meningioma: salvage therapy with long-acting somatostatin analogue.

Authors:  Marc C Chamberlain; Michael J Glantz; Camilo E Fadul
Journal:  Neurology       Date:  2007-09-04       Impact factor: 9.910

6.  Stabilization of disease progression by hydroxyurea in patients with recurrent or unresectable meningioma.

Authors:  Warren P Mason; Fred Gentili; David R Macdonald; Subramanian Hariharan; Charlene R Cruz; Lauren E Abrey
Journal:  J Neurosurg       Date:  2002-08       Impact factor: 5.115

Review 7.  Radiation-induced brain tumours after central nervous system irradiation in childhood: a review.

Authors:  Benedetta Ludovica Pettorini; Young-Soo Park; Massimo Caldarelli; Luca Massimi; Gianpiero Tamburrini; Concezio Di Rocco
Journal:  Childs Nerv Syst       Date:  2008-04-08       Impact factor: 1.475

8.  Intraparenchymal anaplastic meningioma in a child: A rare entity.

Authors:  Khursheed Nayil; Rumana Makhdoomi; Rayees Malik; Altaf Ramzan
Journal:  Asian J Neurosurg       Date:  2015 Apr-Jun

Review 9.  The 2007 WHO classification of tumours of the central nervous system.

Authors:  David N Louis; Hiroko Ohgaki; Otmar D Wiestler; Webster K Cavenee; Peter C Burger; Anne Jouvet; Bernd W Scheithauer; Paul Kleihues
Journal:  Acta Neuropathol       Date:  2007-07-06       Impact factor: 17.088

10.  A retrospective analysis of survival and prognostic factors after stereotactic radiosurgery for aggressive meningiomas.

Authors:  Daniel J Ferraro; Ryan K Funk; John William Blackett; Michelle R Ju; Todd A DeWees; Michael R Chicoine; Joshua L Dowling; Keith M Rich; Robert E Drzymala; Imran Zoberi; Joseph R Simpson; Jerry J Jaboin
Journal:  Radiat Oncol       Date:  2014-01-27       Impact factor: 3.481
View more
  2 in total

1.  Multiplatform profiling of meningioma provides molecular insight and prioritization of drug targets for rational clinical trial design.

Authors:  Richard G Everson; Yuuri Hashimoto; Jacob L Freeman; Tiffany R Hodges; Jason Huse; Shouhao Zhou; Joanne Xiu; David Spetzler; Nader Sanai; Lyndon Kim; Santosh Kesari; Andrew Brenner; Franco De Monte; Amy Heimberger; Shaan M Raza
Journal:  J Neurooncol       Date:  2018-05-30       Impact factor: 4.130

2.  A rare subtype of meningioma: Case series of anaplastic meningioma and review of the literature.

Authors:  Hongyi Cao; Biying Jiang; Yang Zhao; Chuifeng Fan
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.